Drug Profile
Olea pollen allergy immunotherapy - ALK-Abello
Alternative Names: AVANZ olea; AVANZ Olive; AVANZ Olivo; Immunotherapy Olea europaeaLatest Information Update: 15 Dec 2016
Price :
$50
*
At a glance
- Originator ALK-Abello
- Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinoconjunctivitis
Most Recent Events
- 25 Nov 2016 Launched for Allergic rhinoconjunctivitis in Spain before November 2016 (SC) (ALK-Abello email communication)
- 01 Sep 2012 Phase-II/III clinical trials in Allergic rhinoconjunctivitis in Spain (SC)